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The development of activation map-guided surgical tech- 
niques, including encircling ventriculotomy (1) and endocar- 
dial resection (2), was a major breakthrough in the treatment 
of life-threatening ventricular tachyarrhythmias. These tech- 
niques increased the success rate for suppression of sus- 
tained ventricular tachycardia from 21% to 50% (3,4) for 
unguided surgical approaches to 65% to 80%. 
Need for refinement of map-guided surgical ablative ther- 
apy. Despite this appreciable improvement with map-guided 
surgery, there were residual problems that necessitated 
refinements of the technique. Application was difficult in a 
number of patients (24% to 36%) (5,6) whose ventricular 
tachycardia was not inducible intraoperatively and in pa- 
tients with hemodynamically unstable or nonsustained ven- 
tricular tachyarrhythmias, rendering preoperative mapping 
unfeasible. Reliable determination of the site of origin of the 
arrhythmia was often complicated by induction of multiple 
morphologies or by finding anatomically disparate sites of 
origin. Furthermore, some tachyarrhythmias were localized 
to sites of origin remote from obvious areas of aneurysm or 
fibrosis (7). 
The other factor that limited successful endocardial re- 
section was the localization of the site of origin to a region 
that is anatomically inaccessible to complete excision, e.g., 
the inferior wall at the base of the posterior papillary muscle 
(8) or the intramural interventricular septum (9). 
These problems of inadequate mapping of the site of 
origin and its incomplete excision have yielded substantial 
failure rates in specific subpopulations, with up to a 20% to 
35% incidence rate of postoperative inducibility and a 20% to 
30% rate of clinical recurrence of ventricular tachyarrhyth- 
mias (10,ll). 
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Evolutionary refinements of map-guided surgical tech- 
niques. The procedural refinements that were developed to 
obviate the aforementioned problems and improve surgical 
results have focused on adjunctive ablation techniques for 
anatomically inaccessible sites and on mechanisms to ex- 
pand the amount of resected endocardium. 
Cryoablation with a liquid nitrogen probe damages endo- 
cardial electrical function without compromising its struc- 
tural integrity. This has been shown to be quite effective 
alone (12) and in conjunction with endocardial resection of 
inaccessible sites of origin (11). Recently, preliminary re- 
ports (13) have suggested a similar approach using laser 
photoablation of endocardial tissue. 
Expansion of the endocardial resection in situations of 
incomplete mapping uses a more regional approach by 
excising endocardium not only at the site of earliest activa- 
tion, but also at all sites of presystolic activation (7). In 
addition, when disparate sites of origin are found, all sites 
undergo endocardial resection. In cases where mapping is 
unfeasible, visually guided endocardial excision of all border 
zone areas can be applied with improved success rates (14). 
Finally, on-line evaluation of the results of endocardial 
excision, by repeat programmed stimulation to test induc- 
ibility after each endocardial excision, has yielded signifi- 
cantly improved results (5). 
The next step: need for adjunctive automatic implantable 
cardioverter-defibrillator implantation. Despite the afore- 
mentioned innovations, ventricular tachycardia remains in- 
ducible in 10% to 20% of patients postoperatively, and they 
are at high risk for a clinical recurrence of their arrhythmia. 
Furthermore, the negative predictive value of postoperative 
electrophysiologic testing is good but not perfect; there is a 
10% recurrence rate despite noninducibility (5). This has 
suggested the need for other adjunctive therapy, and 
prompted the combined use of the automatic implantable 
cardioverter-defibrillator (AICD) with extended or regional 
subendocardial resection. Platia et al. (IS) demonstrated the 
usefulness of this approach in 1986, but also emphasized the 
morbidity and expense associated with AICD implantation 
and suggested that a selective application should be devel- 
oped. The present report by Manolis et al. (16) in this issue 
of the Journal applies this suggestion and presents a more 
encompassing surgical ablative approach to ventricular 
tachyarrhythmia. 
The authors (16) point out that the AICD lead system can 
be easily and economically placed at the time of endocardial 
resection surgery, thus avoiding the additional morbidity and 
mortality of reoperation for device insertion. Moreover, by 
utilizing the demonstrated risk factors that predict a higher 
incidence of surgical failure (1 I), increased selectivity in 
inserting the AICD lead system can be achieved. 
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Because the ventricular arrhythmia will be noninducible 
postoperatively in most (80% to 90%) of the patients, actual 
implantation of the AICD generator can await the postoper- 
ative electrophysiologic study that allows further risk strat- 
ification. Furthermore. prophylactic AICD lead insertion 
allows for easy access to adjunctive therap!, for the IO% of 
patients whose arrhythmia is not inducible postoperatively, 
but who nonetheless develop clinical recurrences. ‘I‘hus it 
makes benbc to stage the AICD implant&ion. 
Future refinements. The next major evolutionary step 
may be a technical refinement that will obviate the need for 
prophylactic AlC’D lead placement, I.e.. the development of 
a single transvenoub AICD lead in conjunction with minia- 
turization of the AICD generator. This would allow patients 
found to be at increased risk by both anatomic and mapping 
factors and postoperative clectrophysiologic testing to re- 
ceive the new device for approximately 36 months. If there 
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were no clinical recurrences or AICD shocks delivered 
during that period. the generator could be explanted. 
Conclusions. The development of surgical ablative tech- 
niques for life-threatening ventricular tachyarrhythmia is an 
ongoing evolutionary process. At this juncture. the report of 
Manolis et al. (16) outlines a reasoned, systematic approach 
for combining the best techniques of map-guided regional 
and sequential suhendocardial ~csection with or without 
cryoablation and prophylactic AICD patch implantation in 
selected patients to maxirmze effective therapy of life- 
threatcninp \ cntrrcul,ir tachqarrh) thnuas. 
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